Arrowhead Research | ARWR - Przychody Ze Sprzedaży





Obroty Zmiana Data
Agios Pharmaceuticals USD 44.74M 25.94M 2026-06
Alnylam Pharmaceuticals USD 1.29B 120M 2026-06
Anika Therapeutics USD 30.62M 2.8M 2025-12
Arrowhead Research USD 75.23M 1.49M 2026-06
Heron Therapeutics USD 40.59M 2.38M 2025-12
Incyte USD 1.67B 400M 2026-06
Ionis Pharmaceuticals USD 268M 22M 2026-06
Ligand Pharmaceuticals USD 83.7M 31.98M 2026-06
Merck USD 16.6B 310M 2026-06
Moderna USD 100M 289M 2026-06
Nektar Therapeutics USD 10.86M 10.95M 2026-03
Novartis USD 14.41B 1.3B 2026-06
Sarepta Therapeutics USD 401.3M 329.5M 2026-06
TG Therapeutics USD 240.34M 45.54M 2026-06
Ultragenyx Pharmaceutical USD 214M 78M 2026-06
Vertex Pharmaceuticals USD 3.33B 340M 2026-06
Xencor USD 51.22M 46.71M 2026-06